SCI Pharmtech Inc (4119) — Long-term Investment Intensity

Latest as of December 2019: 3.4%

SCI Pharmtech Inc (4119) has a Long-term Investment Intensity of 3.4% as of December 2019. Long-term investments of NT$137.33 Million represent 3.4% of total assets of NT$4.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of SCI Pharmtech Inc to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

3.4%
LT Investments / Total Assets

Long-term Investments

NT$137.33 Million
TWD

Total Assets

NT$4.08 Billion
TWD

Country

Taiwan
TW

SCI Pharmtech Inc Long-term Investment Intensity (2013–2019)

This chart shows how SCI Pharmtech Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 3.4%, reflecting long-term investments of NT$137.33 Million against total assets of NT$4.08 Billion TWD. For the complete balance sheet picture, see SCI Pharmtech Inc assets under control.

Annual Long-term Investment Intensity for SCI Pharmtech Inc (2013–2019)

The table below presents the year-by-year Long-term Investment Intensity for SCI Pharmtech Inc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read SCI Pharmtech Inc debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (TWD) Total Assets Change (pp)
2019 3.4% NT$137.33 Million NT$4.08 Billion ▲ +1.4 pp
2018 2.0% NT$75.30 Million NT$3.79 Billion ▲ +0.7 pp
2017 1.3% NT$42.37 Million NT$3.30 Billion ▲ +0.1 pp
2016 1.2% NT$42.37 Million NT$3.55 Billion ▼ 0.0 pp
2015 1.2% NT$42.37 Million NT$3.46 Billion ▼ -0.3 pp
2014 1.6% NT$50.09 Million NT$3.22 Billion ▲ +0.6 pp
2013 1.0% NT$29.87 Million NT$3.05 Billion
pp = percentage points